홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ADMA
#1300
ADMA Biologics, Inc.
15.5
7
+5.49%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+5.49%
월간 변동
-5.98%
6달 변화
-10.05%
년간 변동율
+1.43%
이전 종가
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
양
204
마켓
주식
헬스케어
ADMA
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
121.28 M
195.92 M
222.16 M
228.22 M
237.62 M
238.16 M
—
Valuation ratios
Enterprise value
180.57 M
225.16 M
773.22 M
987.05 M
3.97 B
4.26 B
16.6 B
Price to earnings ratio
—
-2.76
-11.73
-35
21.17
30.4
92.69
Price to sales ratio
—
2.43
4.97
3.95
9.79
8.76
36.07
Price to cash flow ratio
—
-1.75
-12.87
115.81
35.17
88.64
236.52
Price to book ratio
—
1.39
5.04
7.54
11.96
9.36
19.22
Enterprise value to EBITDA ratio
-1.47
-4.2
-23.46
33.77
27.08
21.34
96.18
Profitability ratios
Return on assets %
-0.36
-0.26
-0.19
0.09
0.4
0.24
0.26
Return on equity %
-0.86
-0.51
-0.43
0.21
0.57
0.31
0.35
Return on invested capital %
-237.14
-139.79
-72.03
35.93
81.62
151.01
146.87
Gross margin %
-45.17
1.45
22.89
34.44
51.48
57.39
228.49
Operating margin %
-153.75
-72.12
-25.55
8.38
32.59
37.53
148.57
EBITDA margin %
-291.35
-66.19
-21.39
11.32
34.4
39.09
154.86
Net margin %
-179.41
-88.52
-42.77
10.94
46.35
28.8
114.11
Liquidity ratios
Quick ratio
3.62
2.77
2.73
1.69
2.9
3.74
13.52
Current ratio
7.71
6.87
6.89
5.16
5.97
6.71
25.74
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.25
0.33
0.49
0.76
1.04
0.92
0.93
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.45
0.34
0.41
0.4
0.15
0.11
0.51
Long term debt to total equity ratio
1.05
0.67
0.94
0.97
0.21
0.15
0.69
Per share metrics
Operating cash flow per share
—
-0.81
-0.3
0.04
0.49
0.21
0.21
EBIT per share
—
-0.42
-0.2
0.1
0.57
0.78
0.78
EBITDA per share
—
-0.38
-0.17
0.13
0.6
0.81
0.81
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0.37
0.44
0.23
0.42
0.36
1.26
Net current asset value per share
—
1.5
1.37
1.15
1.36
1.9
6.6
Tangible book value per share
—
0.97
0.75
0.59
1.42
1.93
6.77
Working capital per share
—
1.28
1.17
0.93
1.13
1.62
5.56
Book value per share
—
1.01
0.77
0.6
1.43
1.95
6.84
뉴스
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Inc Q4 실적 예상치를 넘어, 수익 에상치보다 저조
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
ADMA Biologics 실적 발표 예정: 목표 달성할까?
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
애드마 바이오로직스 사장, 33만 7679달러 상당 주식 매도
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note